14M114: Abstracts: RA – Diagnosis, Manifestations, and Outcomes II: Cardiovascular and Other Comorbidities (1646–1650)

Abstract Moderator(s)

• NS

  Namrata Singh, MD, MSc

  University of Washington
  Bellevue, WA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Beth Wallace, MD, MS

  Michigan Medicine, VA Ann Arbor Healthcare System
  Ann Arbor, MI, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Oral abstract session.

Presentations:

• 9:00 AM – 9:10 AM Eastern Time

  Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs Initiation in Patients with Rheumatoid Arthritis
  

  Presenting Author: Gulsen Ozen, MD – University of Nebraska Medical Center
• 9:10 AM – 9:15 AM Eastern Time

  Q&A
  
• 9:15 AM – 9:25 AM Eastern Time

  Increased Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Matched Cohort Study with Cancer Registry Linkage
  

  Presenting Author: Rebecca Brooks, BS – University of Nebraska Medical Center
• 9:25 AM – 9:30 AM Eastern Time

  Q&A
  
• 9:30 AM – 9:40 AM Eastern Time

  Five-Year Cardiovascular Event Risk in Early Rheumatoid Arthritis Patients Who Received Treat-to-Target Management
  

  Presenting Author: Tsz On Lam, MBBS, MRCP – Prince of Wales Hospital
• 9:40 AM – 9:45 AM Eastern Time

  Q&A
  
• 9:45 AM – 9:55 AM Eastern Time

  Systemic Immune Inflammation Index Predict All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
  

  Presenting Author: Jose Felix Restrepo, MD – University of Texas Health Science center at San Antonio
• 9:55 AM – 10:00 AM Eastern Time

  Q&A